“You can put a pink label on something, but it’s still misogyny,” Jen Gunter told me when I reached her by phone earlier this week. “Goop walked so all these people profiting from wellness on Instagram and TikTok could run.”

The San Francisco–based Kaiser Permanente ob-gyn, never one to mince words , had just been listening to a Megyn Kelly interview with FDA Commissioner Marty Makary —“God help me,” Gunter said, “which is probably why I’m super depressed at the moment, because that’s a double hit right there”—about the so-called expert panel he’d convened regarding the removal of black box warnings from menopause therapies. The panel meeting, per The New York Times, hadn’t featured a presentation of scientific input from FDA scientists; rather, it had included physicians from

See Full Page